Globus Medical, Inc. (BMV:GMED)

Market Cap	199.33B +5.1%
Revenue (ttm)	55.90B +23.5%
Net Income	10.58B +216.2%
EPS	77.32 +221.1%
Shares Out	n/a
PE Ratio	18.85
Forward PE	17.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23
Average Volume	554
Open	1,452.00
Previous Close	n/a
Day's Range	1,452.00 - 1,452.00
52-Week Range	991.50 - 1,670.00
Beta	n/a
RSI	52.61
Earnings Date	May 7, 2026

About Globus Medical

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractu...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 6,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: GMED

Financial Performance

In 2025, Globus Medical's revenue was $2.94 billion, an increase of 16.65% compared to the previous year's $2.52 billion. Earnings were $537.87 million, an increase of 422.28%.

Financial numbers in USD